Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene variants and treatment outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.

The pharmacogenomics journal - 1 Dec 2020

Hessels Arno C, Sanders Jan Stephan F, Rutgers Abraham, Stegeman Coen A

Abstract excerpt

The introduction of immunosuppressive therapy for ANCA-associated vasculitis (AAV) has greatly improved outcomes, though patients now accumulate damage from vasculitis activity and adverse effects of treatment. Prediction of treatment outcomes using gene variants might help reduce this damage by allowing for personalized treatment. Several studies have studied genetic polymorphisms in relation to treatment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Share to Cyclophosphamide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Immunosuppressive Agents

Share to Polymorphism, Single Nucleotide

Share to Treatment Outcome

Source

Identifiers

PMID: 32683418
DOI: 10.1038/s41397-020-0176-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene variants and treatment outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.PMID 32683418Read ↗

Can genetic studies predict treatment response in antineutrophil cytoplasmic antibody-associated vasculitis?Semantic proximity Read ↗

Genetic variants in ANCA-associated vasculitis: a meta-analysis.Semantic proximity Read ↗

Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Update: Genetic Pathogenesis.Semantic proximity Read ↗

Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.Semantic proximity Read ↗

Genetics of ANCA-associated Vasculitides.Semantic proximity Read ↗

Antineutrophil cytoplasm antibody-associated vasculitis: recent developments.Semantic proximity Read ↗

Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and managementSemantic proximity Read ↗

Genetics of ANCA-associated vasculitides: HLA and beyond.Semantic proximity Read ↗

Polymorphisms of the SERPINA1 gene are associated with higher mortality in a Brazilian cohort of ANCA-associated vasculitis patients.Semantic proximity Read ↗

IgA and IgG antineutrophil cytoplasmic antibody engagement of Fc receptor genetic variants influences granulomatosis with polyangiitis.Semantic proximity Read ↗

The genetics of anti-neutrophil cytoplasmic antibody associated vasculitis (AAV)Semantic proximity Read ↗

Meta-analysis revealed HLA susceptibility markers in ANCA-associated vasculitis and its clinical subtypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.